Gene · 10642
IGF2BP1: insulin like growth factor 2 mRNA binding protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IGF2BP1: insulin like growth factor 2 mRNA binding protein 1. Genes, record 10642. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10642
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NZI8 | Insulin-like growth factor 2 mRNA-binding protein 1 | 577 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49916 | Q9NZI8 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3004 | Q9NZI8 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15855 | Q9NZI8 | Espacenet |
| WO 2025125557 A1 | 2025-06-19 | 9 | Q9NZI8 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3004 | Q9NZI8 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15855 | Q9NZI8 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15855 | Q9NZI8 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15694 | Q9NZI8 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4648 | Q9NZI8 | Espacenet |
| US 11946082 B2 | 2024-04-02 | 23 | Q9NZI8 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,445
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IGF2BP1 papers | Newest fiscal year |
|---|---|---|---|
| P30DK050306 | Center for Molecular Studies in Digestive and Liver Diseases | 10 | 2025 |
| R01NS083085 | Mechanism of mRNA Localization and Localized Translation in Neurons | 9 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 5 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| R01AI110221 | The Cell Biology of HIV-1 Genome Trafficking | 4 | 2025 |
| RM1HG008935 | Center for dynamic RNA epitranscriptomes - Renewal | 4 | 2025 |
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 4 | 2025 |
1 to 10 of 1,445Source NIH's project files
See all 1,445 nih grantsPapers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A tripartite mechanism licenses RNA polymerase import into the phage nucleus. | bioRxiv | 2026 | 42818118 | PubTator, text mining | PubMed |
| IGF2BP1-Mediated m6A Modification Enhances the Stability of circ_0088302 to Promote Gastric Cancer Progression. | Adv Biol (Weinh) | 2026 | 42802600 | PubTator, text mining | PubMed |
| IGF2BP1: a double agent in hemoglobin switching. | Blood | 2026 | 42783360 | PubTator, text mining | PubMed |
| Epitranscriptomic stabilization of PGRMC1 by the METTL3-IGF2BP1 axis promotes ovarian cancer progression. | Cell Signal | 2026 | 42777928 | PubTator, text mining | PubMed |
| H3K18la facilitates nasopharyngeal carcinoma progression through the activation of the IGF2BP1-COX2 signaling pathway. | Front Immunol | 2026 | 42774366 | PubTator, text mining | PubMed |
| Stress granule phase transitions and neuronal fate in cerebral ischemia-reperfusion injury. | Front Mol Neurosci | 2026 | 42769600 | PubTator, text mining | PubMed |
| [Preliminary exploration of BBOX1-AS1 as a potential biomarker involved in the regulation of tumor cell proliferation in non-small cell lung cancer]. | Zhonghua Zhong Liu Za Zhi | 2026 | 42764220 | PubTator, text mining | PubMed |
| Epitranscriptomic Regulation of Cardiac Ischemia-Reperfusion Injury: Unveiling the METTL14/IGF2BP1/PDE4D Axis. | Korean Circ J | 2026 | 42750131 | PubTator, text mining | PubMed |
| Helicobacter pylori-Induced Persistent IGF2BP1 Activation Promotes Ferroptosis Resistance in Gastric Tumorigenesis. | Adv Sci (Weinh) | 2026 | 42725716 | PubTator, text mining | PubMed |
| Mapping Allele-specific RBP Binding by a Machine Learning Coupled RNA Editing Strategy in Human Embryonic Stem Cells. | Genomics Proteomics Bioinformatics | 2026 | 42671340 | PubTator, text mining | PubMed |
1 to 10 of 3,895
See all 3,895 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10642
GET https://conductscience.org/api/genes/v1/10642/patents?page=2